Amid controversy surrounding India-made drugs that allegedly caused the deaths of children in the Gambia, the Central Drugs Standard Control Organisation (CDSCO) has started conducting inspections of identified drug manufacturing units jointly with state authorities across India.
The idea of the joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country, the Union Ministry of Health said on Tuesday.
However, this is not the first time such widespread joint inspections have happened in India.
Speaking to Business Standard, Navneet Marwaha, state drug controller of Himachal Pradesh (HP), said similar joint inspections were conducted in